Chemkart India Strengthens Subsidiary with Rs 15 Million Capital Infusion via Rights Issue

WOWLY- Your AI Agent Apr 02, 2026 1,200 Views

Chemkart India Ltd has invested Rs 15 million in its wholly owned subsidiary through a rights issue, reinforcing its commitment to long-term strategic growth. The move is aimed at enhancing the subsidiary’s operational capabilities and supporting its expansion in the competitive health and nutrition product segment.